Laserfiche WebLink
At the time of exposure, any susceptible exposed <br />who has not been previously vaccinated with HBV vaccine <br />should be offered the vaccine. Hepatitis B immune globuli -T. <br />(HBIG) may also be indicated, especially if the source <br />individual found • be positive for ♦: <br />POST -EXPOSURE SCHEDULE <br />Within 24 hours, if possible, after per- <br />cutaneous or permucosal exposure ......... HBIG (0.06 ml/kg) <br />AND HBV vaccine - first dose - .........Engerix (1.0 ml) <br />1 month after 1st dose...................HBVac #2 (1.0 ml) <br />6 months after 1st dose..................HBVac #3 (1.0 ml) <br />----------------------------------------------------------- <br />SUMMARY OF CDC RECOMMENDATION FOR HBV PROPHYLAXIS <br />FOLLOWING PERCUTANEOUSEXPOSURE <br />EXPOSED PERSON <br />SOURCEi VACCINATED <br />per- <br />son for <br />vaccine2.Initiate HBV _ . «, <br />series KBIG immediately, <br />+ HBV vaccine boos- <br />ter <br />ii <br />• • <br />inadequate • <br />less than 10 SRU by <br />RIA, negative ZIA) <br />Known source <br />High-risk 1 -Initiate HBV vaccine <br />series <br />Low-risk <br />Individual 1.Initiate HBV vaccine <br />series <br />Unknown 1.Initiate HBV vaccine <br />series. <br />BIOSAFETY - HBVVAC - 0491 - PAGE 4 <br />vac- <br />cine nonresponder, <br />test source for <br />9BsAg; if source is- <br />7BsAg-pos, <br />x1 immediately + HBV <br />vaccine booster. <br />